A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors

NCT03497429 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda